1. Home
  2. AZTR vs JCSE Comparison

AZTR vs JCSE Comparison

Compare AZTR & JCSE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • JCSE
  • Stock Information
  • Founded
  • AZTR 2014
  • JCSE 1999
  • Country
  • AZTR United States
  • JCSE Singapore
  • Employees
  • AZTR N/A
  • JCSE N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • JCSE Miscellaneous manufacturing industries
  • Sector
  • AZTR Health Care
  • JCSE Consumer Discretionary
  • Exchange
  • AZTR Nasdaq
  • JCSE Nasdaq
  • Market Cap
  • AZTR 3.7M
  • JCSE 5.9M
  • IPO Year
  • AZTR 2023
  • JCSE 2022
  • Fundamental
  • Price
  • AZTR $0.94
  • JCSE $0.92
  • Analyst Decision
  • AZTR
  • JCSE
  • Analyst Count
  • AZTR 0
  • JCSE 0
  • Target Price
  • AZTR N/A
  • JCSE N/A
  • AVG Volume (30 Days)
  • AZTR 1.5M
  • JCSE 11.4K
  • Earning Date
  • AZTR 08-11-2025
  • JCSE 05-15-2025
  • Dividend Yield
  • AZTR N/A
  • JCSE 9.84%
  • EPS Growth
  • AZTR N/A
  • JCSE N/A
  • EPS
  • AZTR N/A
  • JCSE 0.00
  • Revenue
  • AZTR N/A
  • JCSE $14,126,397.00
  • Revenue This Year
  • AZTR N/A
  • JCSE N/A
  • Revenue Next Year
  • AZTR N/A
  • JCSE N/A
  • P/E Ratio
  • AZTR N/A
  • JCSE $198.99
  • Revenue Growth
  • AZTR N/A
  • JCSE 6.92
  • 52 Week Low
  • AZTR $0.81
  • JCSE $0.86
  • 52 Week High
  • AZTR $5.06
  • JCSE $2.39
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 31.60
  • JCSE 38.92
  • Support Level
  • AZTR $0.81
  • JCSE $0.90
  • Resistance Level
  • AZTR $1.07
  • JCSE $1.00
  • Average True Range (ATR)
  • AZTR 0.11
  • JCSE 0.04
  • MACD
  • AZTR 0.00
  • JCSE -0.00
  • Stochastic Oscillator
  • AZTR 22.02
  • JCSE 9.79

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products. Its discovery platform is screened for naturally occurring bacterial cells with beneficial effects. These microbes are then genomically sequenced and engineered to make cellular therapies, recombinant therapeutic proteins, peptides, and small molecules for the precision treatment of dermatology diseases. The company's product candidates include ATR-12, for treating the orphan disease and Netherton syndrome; ATR-04, a genetically modified strain of S. epidermidis for treating the papulopustular rash; and ATR-01, a potential treatment for ichthyosis vulgaris, a chronic, abnormally dry, scaly skin disease.

About JCSE JE Cleantech Holdings Limited

JE Cleantech Holdings Ltd is engaged in the manufacturing and selling of cleaning systems and other equipment that can be categorized into four different categories, namely aqueous washing systems, plating and cleaning systems, train cleaning systems, and other equipment, such as filtration units. The product lives of its cleaning systems and other equipment ranges from two to ten years. The company is also into designing, developing, and manufacturing other cleaning systems for various industrial end-use applications using its R&D and engineering capabilities. The company derives the majority of its revenue from the Sales of cleaning systems and other equipment. Geographically, the company derives a majority of its revenue from Singapore, followed by Malaysia.

Share on Social Networks: